913239-57-3

Upstream product

• 152120-54-2 N,N'-bis( tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine 
• 695171-95-0 diphenyl 1-benzyloxycarbonylamino-2-(4-(tert-butyloxycarbonylamino)phenyl)ethanephosphonate 
• 934622-37-4 benzyl 2-(4-aminophenyl)-1-(diphenoxyphosphoryl)ethylcarbamate 
• 695171-91-6 4-(tert-butyloxycarbonylamino)phenylacetaldehyde 
• 104-10-9 2-(4'-aminophenyl)ethyl alcohol 
• 104060-23-3 tert-butyl N-[4-(2-hydroxyethyl)phenyl]carbamate 
• 71989-33-8 Nα-(9-fluorenylmethoxycarbonyl)-D-serine-tert-butyl ether 
• 695172-02-2 diphenyl 1-(benzyloxycarbonylamino)-2-{4-[N,N'-bis(tert-butyloxycarbonyl)guanidino]phenyl}ethanephosphonate 
• 118-90-1 ortho-methylbenzoic acid 
• 913239-43-7 [(N-o-methylbenzoyl-O-tert-butyl)-D-seryl]-L-alanine 
• 913239-29-9 diphenyl 1-amino-2-{4-[N,N'-bis(tert-butyloxycarbonyl)guanidino]phenyl}ethanephosphonate 

Relevant academic research and scientific papers

Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: Optimization of the P4 position

This paper describes the structure-activity relationship in a series of tripeptidyl diphenyl phosphonate irreversible urokinase plasminogen activator (uPA) inhibitors, originally derived from an arginyltripeptide. uPA is considered an interesting target i